90 related articles for article (PubMed ID: 6156420)
21. Antileukemic activity of 5-aza-2'-deoxycytidine and cytarabine against intracerebral L1210 murine leukemia.
Chabot GG; Momparler RL
Cancer Treat Rep; 1984 Dec; 68(12):1483-7. PubMed ID: 6210142
[TBL] [Abstract][Full Text] [Related]
22. Transformation and metabolic effects of 5-aza-2'-deoxycytidine in mice.
Cihak A; Vesely J; Hynie S
Biochem Pharmacol; 1980 Nov; 29(21):2929-32. PubMed ID: 6161616
[No Abstract] [Full Text] [Related]
23. Antagonism of 5-aza-2'-deoxycytidine antileukemic activity by concomitant treatment with cytarabine.
Colombo T; Rossi C; D'Incalci M
Cancer Treat Rep; 1986 Dec; 70(12):1451-3. PubMed ID: 2431776
[TBL] [Abstract][Full Text] [Related]
24. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
Bhalla K; Cole J; MacLaughlin W; Arlin Z; Baker M; Graham G; Grant S
Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450
[TBL] [Abstract][Full Text] [Related]
25. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
Momparler RL; Rossi M; Bouchard J; Vaccaro C; Momparler LF; Bartolucci S
Mol Pharmacol; 1984 May; 25(3):436-40. PubMed ID: 6203026
[TBL] [Abstract][Full Text] [Related]
26. Deoxycytidine kinase from human leukemic spleen: preparation and characteristics of homogeneous enzyme.
Bohman C; Eriksson S
Biochemistry; 1988 Jun; 27(12):4258-65. PubMed ID: 2844225
[TBL] [Abstract][Full Text] [Related]
27. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
Balzarini J; De Clercq E
Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
[TBL] [Abstract][Full Text] [Related]
28. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Brockman RW; Cheng YC; Schabel FM; Montgomery JA
Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
[TBL] [Abstract][Full Text] [Related]
29. Effect of intravenous infusion of 5-aza-2'-deoxycytidine on survival time of mice with L1210 leukemia.
Momparier RL; Gonzales FA
Cancer Res; 1978 Sep; 38(9):2673-8. PubMed ID: 79443
[No Abstract] [Full Text] [Related]
30. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
31. Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate.
Hughes TL; Hahn TM; Reynolds KK; Shewach DS
Biochemistry; 1997 Jun; 36(24):7540-7. PubMed ID: 9200705
[TBL] [Abstract][Full Text] [Related]
32. Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells.
Covey JM; D'Incalci M; Tilchen EJ; Zaharko DS; Kohn KW
Cancer Res; 1986 Nov; 46(11):5511-7. PubMed ID: 2428479
[TBL] [Abstract][Full Text] [Related]
33. Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase.
Bouchard J; Momparler RL
Mol Pharmacol; 1983 Jul; 24(1):109-14. PubMed ID: 6191192
[TBL] [Abstract][Full Text] [Related]
34. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
White JC; Capizzi RL
Cancer Res; 1991 May; 51(10):2559-65. PubMed ID: 2021937
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
Veselý J; Pískala A
Neoplasma; 1986; 33(1):3-10. PubMed ID: 2421173
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
Momparler RL; Côté S; Eliopoulos N
Leukemia; 1997 Mar; 11 Suppl 1():S1-6. PubMed ID: 9130684
[TBL] [Abstract][Full Text] [Related]
37. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
Antonsson BE; Avramis VI; Nyce J; Holcenberg JS
Cancer Res; 1987 Jul; 47(14):3672-8. PubMed ID: 2439195
[TBL] [Abstract][Full Text] [Related]
38. Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.
Ahluwalia GS; Cohen MB; Kang GJ; Arnold ST; McMahon JB; Dalal M; Wilson YA; Cooney DA; Balzarini J; Johns DG
Cancer Res; 1986 Sep; 46(9):4479-85. PubMed ID: 2425954
[TBL] [Abstract][Full Text] [Related]
39. A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: a model for nucleoside kinase action.
Turk B; Awad R; Usova EV; Björk I; Eriksson S
Biochemistry; 1999 Jun; 38(26):8555-61. PubMed ID: 10387103
[TBL] [Abstract][Full Text] [Related]
40. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
Chabot GG; Momparler RL
Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
